Recent Updates
Recently added Catalysts
FULC Positive Sentiment Score: 72/100

Fulcrum Therapeutics to Participate at the Upcoming SVB Securities Global Biopharma Conference

Wednesday, February 8, 2023 1 min read
Key Takeaway: Fulcrum Therapeutics, a clinical-stage biopharmaceutical company, announced its participation in the upcoming SVB Securities Global Biopharma Conference on February 15, 2023. The presentation is set to be virtual, allowing a wide audience to access it. The event presents an opportunity for Fulcrum to highlight its focus on genetically defined rare diseases and potentially attract further investor interest.

Market Sentiment Analysis

POSITIVE FACTORS

  • Fulcrum Therapeutics is participating in a prominent industry conference.
  • The presentation aims to showcase their advancements in the biopharma field.
  • The event may enhance visibility and investor interest in their work.

Full Press Release Details

CAMBRIDGE, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that management will participate in a virtual presentation at the SVB Securities Global Biopharma Conference on Wednesday, February 15, 2023 at 10:00 AM ET.
The webcast of the presentation will be accessible here and through the Investor Relations section of the Fulcrum website at https://ir.fulcrumtx.com/events-and-presentations. An archived replay will be available on the Company’s website for 90 days.
About Fulcrum Therapeutics
LifeSci Advisors, LLC
ccalabrese@lifesciadvisors.com
Executive Director, Corporate Communications
Fulcrum Therapeutics, Inc.
dsmith@fulcrumtx.com

Frequently Asked Questions

When will Fulcrum Therapeutics present at the biopharma conference?

Fulcrum Therapeutics will present on February 15, 2023, at 10:00 AM ET.

Where can I watch the Fulcrum Therapeutics presentation?

The presentation will be accessible on the Fulcrum website's Investor Relations section.

How long will the presentation replay be available?

The archived replay will be available for 90 days on the company's website.

What kind of diseases does Fulcrum Therapeutics focus on?

They focus on improving the lives of patients with genetically defined rare diseases.

Tags: FULC Viatris Investor Conferences Healthcare Fulcrum Therapeutics SVB Securities biopharmaceutical global conference genetically defined diseases
Last updated: Feb 8, 2023